Granulomatosis with Polyangiitis: Clinical Trials

13 trials for Granulomatosis with Polyangiitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated, 3 completed, 3 unknown, 2 recruiting. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Terminated 4, Completed 3, Unknown 3, Recruiting 2, Not yet recruiting 1

Follow Granulomatosis with Polyangiitis: new trials by email Literature Review of Granulomatosis with Polyangiitis trials Research Report on Granulomatosis with Polyangiitis

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA)
Phase 4RecruitingUniversity of Sao Paulo General Hospital4772026-03-162026-07-20
Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
Rituximab - ANCA Associated Vasculitis (AAV), Polyangiitis (GPA)
Phase 4Not yet recruitingAssistance Publique - Hôpitaux de Paris702026-02-012026-03-05
Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis
Avacopan, prednisolone and rituximab, Prednisolone and rituximab - ANCA Associated Vasculitis (AAV)
Phase 4RecruitingChiba University1602024-11-152025-05-04
Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
Tofacitinib, Methotrexate - Granulomatosis With Polyangiitis
Phase 4UnknownShanghai Zhongshan Hospital662021-07-012021-07-09
Hydroxychloroquine in ANCA Vasculitis Evaluation
Hydroxychloroquine, Placebo - ANCA Associated Vasculitis, Microscopic Polyangiitis
Phase 4TerminatedGuy's and St Thomas' NHS Foundation Trust432020-12-172026-04-29
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Rituximab, Placebo - Granulomatosis With Polyangiitis (Wegener's Granulomatosis)
Phase 4TerminatedHospital for Special Surgery, New York32015-12-012018-03-22
A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
Methylprednisolone, Prednisone, Rituximab - Wegener's Granulomatosis or Microscopic Polyangiitis
Phase 4CompletedHoffmann-La Roche302015-07-062022-07-06
Low-dose Glucocorticoid Vasculitis Induction Study
Rituximab, Glucocorticoids - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis
Phase 4UnknownChiba University1402014-10-012021-01-27
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Glucocorticoids, Rituximab - Granulomatosis With Polyangiitis, Microscopic Polyangiitis
Phase 4CompletedMassachusetts General Hospital202014-06-012021-06-25
Alemtuzumab for ANCA Associated Refractory Vasculitis
Alemtuzumab - Vasculitis, Microscopic Polyangiitis
Phase 4UnknownCambridge University Hospitals NHS Foundation Trust242011-02-012011-07-29
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
CryoSpray Ablation - Lung Diseases, Obstructive, Sarcoidosis
Phase 4TerminatedCSA Medical, Inc.52008-10-012015-08-18
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
prednisone, methylprednisolone,cyclophosphamides, Cyclophosphamide, Azathioprine,prednisone,methylprednisolone, Mycophenolate mofetil,methotrexate - Vasculitis, Wegener's Granulomatosis
Phase 4CompletedAssistance Publique - Hôpitaux de Paris1082005-07-012011-09-12
Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
azathioprine - Vasculitis
Phase 4TerminatedUniversity Medical Center Groningen1312003-06-012018-12-13

Narrower conditions

Microscopic Polyangiitis (9)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (5)  ·  Vasculitis (3)  ·  Churg-Strauss Syndrome (2)  ·  Antiphospholipid Syndrome (1)  ·  Arthritis, Juvenile (1)  ·  Arthritis, Psoriatic (1)  ·  Arthritis, Rheumatoid (1)  ·  Axial Spondyloarthritis (1)  ·  Lung Diseases, Obstructive (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Myositis (1)  ·  Polyarteritis Nodosa (1)  ·  Recurrent respiratory papillomatosis (1)

Broader conditions

Autoimmune Diseases (13)  ·  Cardiovascular Diseases (13)  ·  Immune System Diseases (13)  ·  Lung Diseases (13)  ·  Lung Diseases, Interstitial (13)  ·  Respiratory Tract Diseases (13)  ·  Skin Diseases (13)  ·  Skin Diseases, Vascular (13)  ·  Skin and Connective Tissue Diseases (13)  ·  Vascular Diseases (13)  ·  Systemic Vasculitis (12)  ·  Vasculitis (10)  ·  Brain Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Cerebral Small Vessel Diseases (9)

Interventions

Rituximab (6)  ·  Prednisone (3)  ·  Azathioprine (2)  ·  Glucocorticoids (2)  ·  Methotrexate (2)  ·  Methylprednisolone (2)  ·  Prednisolone (2)  ·  Alemtuzumab (1)  ·  Cryoelectron Microscopy (1)  ·  Cryosurgery (1)  ·  Cryotherapy (1)  ·  Cyclophosphamide (1)  ·  Hydroxychloroquine (1)  ·  Mycophenolic Acid (1)  ·  Vaccines (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Chiba University (2)  ·  CSA Medical, Inc. (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Guy's and St Thomas' NHS Foundation Trust (1)  ·  Hoffmann-La Roche (1)  ·  Hospital for Special Surgery, New York (1)  ·  Massachusetts General Hospital (1)  ·  Shanghai Zhongshan Hospital (1)  ·  University Medical Center Groningen (1)  ·  University of Sao Paulo General Hospital (1)

Countries

United States (3)  ·  France (2)  ·  Japan (2)  ·  United Kingdom (2)  ·  Brazil (1)  ·  China (1)  ·  India (1)  ·  Netherlands (1)

Top investigators

Coen A Stegeman, MD, PhD (1)  ·  David D'Cruz (1)  ·  David RW Jayne, MD MRCP (1)  ·  Hiroshi Nakajima, M.D., Ph.D (1)  ·  John H Stone, MD (1)  ·  Lindi Jiang, PhD (1)  ·  Masayoshi Harigai, MD, PhD (1)  ·  Michael Machuzak, M.D. (1)  ·  Robert F Spiera, MD (1)

Results publications

PMID 34061144, PMID 19054820, PMID 23045170, PMID 25693055, PMID 27242368, PMID 29247107, PMID 33164993, PMID 33596356, PMID 35110332, PMID 35110333, PMID 35365179, PMID 36927642, PMID 37024906, PMID 37734880, PMID 9041949

NIH funding

2009 (1), 2018 (1), 2025 (1)